文献速递妇科

无症状绝经后子宫阴道脱垂女性子宫内膜息肉的患病率及危险因素

Prevalence of and risk factors for endometrial polyps among asymptomatic postmenopausal women with uterovaginal prolapse.
PubMed 文献 · Am J Obstet Gynecol · 2024-08-08

本横断面研究纳入2009至2018年在华盛顿州单中心因子宫阴道脱垂行子宫切除术的无症状绝经后女性317例,病理检出子宫内膜息肉106例(33.4%)。多因素logistic回归显示高体重指数(OR 1.06,95%CI 1.01-1.12,P=.02)和绝经激素治疗(OR 1.67,95%CI 1.02-2.72,P=.04)与息肉独立相关。作者认为意外发现的无症状息肉可考虑期待管理。

要点

  • 无症状绝经后脱垂子宫切除者子宫内膜息肉患病率为33.4%(106/317)。
  • 高体重指数(OR 1.06,95%CI 1.01-1.12,P=.02)与息肉独立相关。
  • 绝经激素治疗(OR 1.67,95%CI 1.02-2.72,P=.04)与息肉独立相关。

核心结论

  • 因子宫阴道脱垂行子宫切除术的无症状绝经后女性子宫内膜息肉患病率高。
  • 使用绝经激素治疗和高体重指数者发生子宫内膜息肉的风险更高。
  • 恶性风险似乎较低,但需进一步研究以真正量化终生风险。
  • 作者认为,对于意外发现的无症状息肉,期待管理可能是合理的方法。

研究设计与样本

  • 横断面研究,评估因子宫阴道脱垂行子宫切除术的无症状绝经后女性子宫内膜息肉患病率。
  • 排除因其他指征(包括绝经后出血)行子宫切除术者。
  • 纳入2009至2018年在华盛顿州单中心接受诊疗的317例合格患者。
  • 主要结局为病理学检出子宫内膜息肉,采用单因素分析和多因素回归评估相关危险因素。

主要发现

  • 317例合格女性中106例(33.4%)检出子宫内膜息肉。
  • 息肉平均大小13±10 mm,子宫内膜厚度平均1.4±1.5 mm。
  • 多数病例(78%)为单发息肉。
  • 癌前和恶性病变2例(1.89%),其中1例子宫内膜癌、1例子宫内膜上皮内瘤变。
  • 有无子宫内膜息肉患者的基础临床和人口学特征相似,包括子宫肌瘤、子宫内膜异位症和子宫腺肌病的存在。

临床怎么用

  • 作者认为,对于意外发现的无症状息肉,期待管理可能是合理的方法。
  • 作者指出,恶性风险似乎较低,但需进一步研究以真正量化终生风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of endometrial polyps among asymptomatic, postmenopausal women is not well defined. There is no clear clinical consensus on how to manage endometrial polyps in this population and whether these polyps truly are a cause for clinical concern. OBJECTIVE: This study aimed to estimate the prevalence of endometrial polyps among asymptomatic (without bleeding), postmenopausal women and to evaluate risk factors associated with their presence. STUDY DESIGN: This cross-sectional study assessed the prevalence of endometrial polyps among asymptomatic, postmenopausal women who underwent a hysterectomy for uterovaginal prolapse. Patients were excluded if they underwent a hysterectomy for other indications, including postmenopausal bleeding. Following chart review, eligible patients who received care at a single site in Washington state from 2009 to 2018 were included. The primary outcome was the presence of endometrial polyps on pathology. Risk factors associated with polyp prevalence were subsequently assessed using univariate analysis and multivariate regression. RESULTS: Of the 317 eligible women identified, endometrial polyps were identified in 106 women (33.4%). The average polyp size and endometrial thickness was 13±10 mm and 1.4±1.5 mm, respectively. Most cases (78%) had solitary polyps. Premalignant and malignant lesions were found in 2 cases (1.89%); 1 had endometrial carcinoma and 1 had endometrial intraepithelial neoplasia. Baseline clinical and demographic characteristics were similar between patients with and those without endometrial polyps, including the presence of fibroids, endometriosis, and adenomyosis. A multivariate logistic regression showed that the presence of polyps was independently associated with a high body mass index (odds ratio, 1.06; 95% confidence interval, 1.01-1.12; P=.02) and use of menopausal hormone therapy (odds ratio, 1.67; 95% confidence interval, 1.02-2.72; P=.04). CONCLUSION: Asymptomatic postmenopausal women who underwent hysterectomy for uterovaginal prolapse exhibited a high prevalence of endometrial polyps. Those who used menopausal hormone therapy and who had a high body mass index were at a higher risk for developing endometrial polyps. Although the risk for malignancy seems to be low, more investigation is warranted to truly quantify the lifetime risk. For now, expectant management may be a reasonable approach for incidentally found, asymptomatic polyps.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Weigel GM, Baison GN, Mihalov L, et al. Prevalence of and risk factors for endometrial polyps among asymptomatic postmenopausal women with uterovaginal prolapse. Am J Obstet Gynecol. 2024. PMID: 39127165. doi:10.1016/j.ajog.2024.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。